| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate |
2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37531fdd6c2b19f7a84ee5a3d8050721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00bd69b9d5c8e63762316089c4f84d6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d05f511856efcdf19c5af8b83aecc132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04095d2cae122d67001ef245cddef8e |
| publicationDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109475621-A |
| titleOfInvention |
Combined immunosuppressive method of anti-CD20 monoclonal antibody and tacrolimus in xenograft corneal transplantation |
| abstract |
The present invention relates to a regimen for inhibiting immune rejection that can occur during corneal xenotransplantation. According to the immunoreaction suppression method of the present invention, not only can the recipient effectively suppress the immune rejection caused by the cornea transplanted after the full-thickness xenotransplantation of the cornea, but also the living transplant of the cornea can be stably maintained for a long period of time. , and can effectively maintain indicators such as corneal thickness and intraocular pressure, so it can be effectively used in xenotransplantation. |
| priorityDate |
2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |